Peter Goodhand
$321,484.80asExecutive Lead
Employed by Ontario Institute For Cancer Research in 2025, according to Government of Ontario public salary records.
Salary Information
Historical salary and taxable benefits from 2016 to 2025.
Peter Goodhand, Executive Lead at Ontario Institute For Cancer Research, earned a disclosed salary of $321,484.80 in 2025 on the Ontario Sunshine List. Peter Goodhand has appeared on the Ontario Sunshine List 10 times between 2016 and 2025, with reported earnings peaking at $395,133.60 in 2017. In addition to salary, $677.16 in taxable benefits was disclosed for 2025. Ontario Institute For Cancer Research reports under the Other Public Sector Employers sector of Ontario's public sector salary disclosure.
Top earning Executive Leads in Ontario Institute For Cancer Research
| Name | Salary |
|---|---|
| Peter Goodhand | $321,484.80 |
Top earning Executive Leads in Ontario
| Name | Salary | Employer |
|---|---|---|
Algonquin College Of Applied Arts and Technology | $243,020.26 | Algonquin College Of Applied Arts and Technology |
Riverside Health Care Facilities Inc. | $149,908.14 | Riverside Health Care Facilities Inc. |
Rideau Community Health Services | $143,802.55 | Rideau Community Health Services |
Solicitor General | $115,262.92 | Solicitor General |
Other employees at Ontario Institute For Cancer Research
| Name | Position | Salary |
|---|---|---|
| Leslie Radvanyi President and Scientific Director | President and Scientific Director | $539,745.00 |
| Christine Williams Acting President and Head, Implementation Science | Acting President and Head, Implementation Science | $395,996.12 |
| Lincoln Stein Acting Scientific Director and Head, Adaptive Oncology | Acting Scientific Director and Head, Adaptive Oncology | $383,286.80 |
| Jared T. Simpson Interim Scientific Director and Principal Investigator | Interim Scientific Director and Principal Investigator | $331,897.15 |
| David E. Uehling Interim Scientific Director, Therapeutic Innovation and Drug Discovery | Interim Scientific Director, Therapeutic Innovation and Drug Discovery | $329,520.45 |
| Jeanette Dias D'Souza Senior Vice President, Group Chief Financial Officer | Senior Vice President, Group Chief Financial Officer | $319,995.00 |
| Robert V. Campos Senior Director | Senior Director | $256,531.19 |
| Rebecca L. Tamarchak Head, Strategy, Governance and Partnerships | Head, Strategy, Governance and Partnerships | $249,995.20 |
| David M Sutton Senior Director | Senior Director | $240,445.77 |
| Juri Reimand Principal Investigator | Principal Investigator | $233,643.01 |